|1.||Brandt, Ernst: 2 articles (07/2004 - 02/2002)|
|2.||Vlodavsky, I: 2 articles (12/2000 - 10/2000)|
|3.||Eldor, A: 2 articles (12/2000 - 10/2000)|
|4.||Friedmann, Y: 2 articles (12/2000 - 10/2000)|
|5.||Klement, Giannoula Lakka: 1 article (01/2013)|
|6.||Zdrazilova-Dubska, Lenka: 1 article (01/2013)|
|7.||Pilatova, Katerina: 1 article (01/2013)|
|8.||Bencsikova, Beatrix: 1 article (01/2013)|
|9.||Demlova, Regina: 1 article (01/2013)|
|10.||Greplova, Kristina: 1 article (01/2013)|
|1.||Lung Neoplasms (Lung Cancer)
06/10/2009 - "In two independent population cohorts, CTAP III/NAP-2 was significantly associated with lung cancer and improved the accuracy of a lung cancer risk prediction model that included age, smoking, lung function (FEV(1)), and an interaction term between FEV(1) and CTAP III/NAP-2 (area under the curve, 0.84; 95% CI, 0.77 to 0.91) compared to CAPIII/NAP-2 alone. "
08/22/2012 - "As a demonstration of the approach, we report the rapid development of a made-to-order electronic sensor for a newly reported early biomarker for lung cancer (CTAP III/NAP2). "
05/15/2011 - "Our findings demonstrate elevated plasma levels of CTAP-III occur in lung cancer patients. "
05/15/2011 - "We also quantified and verified the increased levels of plasma CTAP-III with ELISA in patients with lung cancer (mean ± SD, 1859 ± 1219 ng/mL) compared to controls (698 ± 434 ng/mL; P<0.001). "
06/10/2009 - "We identified CTAP III/NAP-2 as a novel biomarker to detect preclinical lung cancer. "
06/10/2009 - "CTAP III/NAP-2 levels decreased after tumor resection (P = .01). "
10/01/2000 - "The aim of this study was to explore the possible involvement of CTAP-III in the development of cervical cancer as it progresses through several cervical intraepithelial neoplasia (CIN) stages. "
01/01/2013 - "Here, we review the role of PF-4 and CTAP-III in the regulation of tumor angiogenesis; the results of clinical trial using recombinant PF-4 (rPF-4); and the use of PF-4 and CTAP-III as cancer biomarkers. "
01/01/2013 - "Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology."
10/01/1987 - "The human tumor cell cDNA hybridizing with the Chinese hamster clone was isolated, sequenced, and found to have closer similarity to the Chinese hamster gene than to CTAP III. Thus, the cloned cDNAs from Chinese hamster and human cells represent a different gene, named gro. "
|3.||Cervical Intraepithelial Neoplasia
03/01/1988 - "Connective tissue-activating peptide released at the inflammation site could be having a systemic effect. "
01/01/1978 - "CTAP-III is a potent connective tissue mitogen, and promotes glycolysis and glycosaminoglycan synthesis, characteristics which make it an interesting candidate for a role as a mediator of inflammation."
01/01/1973 - "V. The flux of connective tissue activating peptide during acute inflammation."
10/17/2006 - "Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation."
02/21/1997 - "NAP-2 strongly stimulates neutrophils that are present during inflammation whereas its precursors, PBP and CTAP-III, are inactive, although they also possess the highly conserved, amino-terminal sequence, Glu-Leu-Arg (ELR), that is critical for receptor binding. "
|5.||Melanoma (Melanoma, Malignant)
01/17/1997 - "Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation."
06/01/1995 - "Other prominent members are melanoma growth stimulatory activity (GRO-alpha), neutrophil-activating peptide-2, and epithelial-cell derived neutrophil-activating protein 78. "
01/17/1997 - "Neutrophil-activating peptide-2 (NAP-2) and melanoma growth-stimulatory activity (MGSA) are members of the chemokine family of inflammatory proteins. "
04/29/1994 - "Human and rabbit IL-8 receptor subtype A binds IL-8 and structurally related peptide melanoma growth-stimulating activity (MGSA) and neutrophil-activating peptide-2 (NAP-2) according to the following affinity binding profile: IL-8 >>> MGSA > NAP-2, whereas the human IL-8 receptor subtype B profile is IL-8 = MGSA > NAP-2 (LaRosa, G., Thomas, K. "
03/01/1993 - "Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2."
|1.||Interleukin-8 (Interleukin 8)
|2.||connective tissue-activating peptide (CTAP-III)
|3.||Proteins (Proteins, Gene)
|4.||Platelet Factor 4
|6.||Protein Isoforms (Isoforms)